despit
reduc
mortal
rate
recent
year
pneumonia
foremost
caus
death
infecti
diseas
children
worldwid
account
total
death
mostli
develop
hypoxemia
frequent
associ
pneumonia
marker
diseas
sever
lead
increas
risk
death
children
cochran
report
systemat
hypoxemia
screen
puls
oximetri
appropri
oxygen
suppli
effect
prevent
death
pneumonia
children
larg
simul
studi
estim
systemat
puls
oximetri
may
global
prevent
almost
death
pneumonia
howev
microbiolog
agent
link
hypoxem
pneumonia
poorli
recogn
identif
etiolog
agent
would
serv
better
target
prevent
ie
vaccin
cur
measur
ie
antibiot
antivir
drug
reduc
global
burden
hypoxemia
pneumonia
high
incid
relat
mortal
particular
attent
must
paid
hypoxem
pneumonia
develop
countri
puls
oximetri
still
rare
avail
healthcar
set
develop
absenc
oximet
hypoxemia
detect
sever
clinic
sign
symptom
includ
cyanosi
increas
respiratori
rate
howev
none
sensit
specif
enough
reliabl
detect
studi
hypoxemia
children
pneumonia
perform
one
countri
rare
investig
relationship
hypoxemia
microbiolog
result
would
use
reassess
recent
multicontinent
risk
factor
death
among
children
pneumonia
develop
countri
alreadi
rare
regard
relationship
microbiolog
find
mortal
assess
clinic
paraclin
microbiolog
predictor
death
would
use
priorit
public
health
campaign
identif
microbiolog
agent
associ
death
andor
hypoxemia
would
use
better
focu
therapeut
measur
inde
hypoxem
pneumonia
treat
oxygen
conjunct
measur
wherea
nonhypoxem
pneumonia
poor
vital
prognosi
might
need
regimen
antibioticsantivir
intens
care
object
present
studi
assess
microbiolog
agent
link
hypoxemia
hospit
children
pneumonia
develop
countri
identifi
clinic
paraclin
predictor
hypoxemia
pinpoint
factor
associ
death
within
week
admiss
find
prospect
hospitalbas
multicent
longitudin
studi
conduct
five
site
four
countri
locat
three
contin
analyz
lucknow
vadu
india
antananarivo
madagascar
bamako
mali
san
lorenzo
paraguay
particip
site
member
gabriel
global
approach
biolog
research
infecti
diseas
epidem
lowincom
countri
network
establish
fondat
studi
protocol
site
describ
pneumonia
case
origin
studi
follow
hospit
stay
constitut
analyz
cohort
studi
popul
compris
children
age
month
compli
protocol
definit
inclus
criteria
elig
patient
identifi
studi
clinician
particip
site
consecut
patient
hospit
pediatr
depart
elig
studi
entri
enrol
season
dri
raini
least
period
studi
aim
obtain
equal
number
individu
season
studi
site
incid
case
defin
hospit
children
age
month
clinic
featur
pneumonia
describ
latter
radiolog
confirm
pneumonia
chest
xray
per
world
health
organ
inform
consent
statement
sign
children
parent
legal
guardian
wheez
auscult
initi
exclus
criterion
amend
slow
inclus
process
thu
final
decid
includ
children
present
pneumonia
without
wheez
present
studi
select
compris
site
better
qualiti
data
oxygen
satur
admiss
mortal
among
pneumonia
case
document
record
patient
followup
hospit
main
characterist
compar
site
multivari
analysi
account
heterogen
site
regard
observ
nonobserv
potenti
confound
factor
patient
miss
data
followup
measur
vital
statu
discharg
exclud
n
exclud
patient
differ
analyz
gender
weightforheight
z
score
older
p
pneumonia
case
defin
follow
criteria
andor
delin
children
month
age
breath
rate
cycl
per
minut
children
month
age
breath
rate
cycl
per
minut
symptom
appear
within
last
confirm
pneumonia
per
guidelin
includ
primari
endpoint
pneumonia
data
qualiti
monitor
evalu
site
emerg
pathogen
laboratori
lyon
franc
pool
data
analysi
demograph
characterist
underli
diseas
medic
histori
clinic
examin
enrol
therapeut
vaccin
outcom
record
prospect
patient
standard
paper
form
potenti
error
discuss
local
investig
final
rule
appli
princip
investig
site
inform
qualiti
assess
involv
resolut
hypoxemia
defin
accord
measur
hospit
admiss
administr
oxygen
therapeut
vital
statu
record
patient
discharg
sampl
collect
first
hour
patient
hospit
nasal
swabsaspir
whole
blood
pleural
effus
case
pleurisi
sampl
patient
urin
collect
patient
admiss
ascertain
histori
antibiot
use
biolog
sampl
taken
inhospit
administr
antibiot
whole
blood
allow
complet
blood
count
cultur
realtim
multiplex
polymeras
chain
reaction
rtpcr
assay
identif
staphylococcu
aureu
streptococcu
pneumonia
haemophilu
influenza
type
b
c
reactiv
protein
crp
procalcitonin
pct
quantifi
serum
respiratori
specimen
permit
identif
virus
bacteria
rtpcr
assay
panel
virus
five
bacteria
fasttrack
diagnost
respiratori
pathogen
plu
fasttrack
diagnost
eschsuralzett
luxemburg
name
influenza
viru
influenza
viru
influenza
viru
b
coronaviru
coronaviru
coronaviru
coronaviru
human
parainfluenza
viru
human
metapneumovirus
hmpv
b
rhinoviru
respiratori
syncyti
viru
rsv
b
adenoviru
enteroviru
parechoviru
bocaviru
mycoplasma
pneumonia
chlamydia
pneumonia
aureu
pneumonia
h
influenza
type
b
streptococcu
pneumoniaeposit
specimen
serotyp
multiplex
rtpcr
detect
differ
serotyp
central
blind
pcr
respiratori
qualiti
control
panel
provid
site
ensur
procedur
valid
onsit
specimen
process
local
qualit
variabl
describ
number
percentag
comparison
test
appropri
fischer
exact
test
quantit
variabl
report
median
interquartil
rang
iqr
compar
u
test
oneway
analysi
varianc
posit
likelihood
lr
neg
likelihood
ratio
variou
clinic
sign
symptom
calcul
detect
hypoxem
case
follow
formula
lr
sensit
specif
sensit
specif
underlin
lr
calcul
use
improv
diagnost
lr
could
thu
express
proport
hypoxem
children
present
particular
sign
symptom
divid
proport
nonhypoxem
children
result
microbiolog
find
differ
sampl
site
associ
hypoxemia
assess
logist
regress
model
multivari
analysi
perform
univari
analysi
forc
adjust
patient
age
time
per
quarter
studi
center
microorgan
p
valu
univari
analysi
initi
enter
multivari
model
thu
backward
stepwis
delet
appli
p
valu
model
compar
wald
test
factor
associ
inhospit
mortal
assess
curv
compar
logrank
test
followup
censor
day
admiss
discharg
durat
hospit
less
day
characterist
patient
deceas
within
week
n
compar
nondeceas
patient
n
univari
bivari
proport
hazard
cox
regress
analys
undertaken
multivari
cox
model
fit
owe
limit
number
event
bivari
analys
express
effect
one
major
risk
factor
univari
analysi
adjust
one
possibl
confound
age
categori
human
immunodefici
viru
hiv
seroposit
time
per
quarter
weightforheight
z
score
test
two
tail
p
consid
signific
statist
analysi
conduct
stata
version
statacorp
colleg
station
tx
studi
protocol
inform
consent
statement
clinic
research
form
amend
studi
document
submit
approv
institut
research
ethic
committe
site
overal
children
pneumonia
account
hospit
day
includ
among
male
median
age
month
iqr
month
ninetysix
patient
came
lucknow
india
vadu
india
antananarivo
madagascar
bamako
mali
san
lorenzo
paraguay
studi
period
site
august
decemb
lucknow
june
march
vadu
februari
decemb
antananarivo
juli
novemb
bamako
may
may
san
lorenzo
patient
differ
site
accord
median
weightforheight
z
score
p
age
categori
p
differ
site
accord
hiv
seroposit
p
mortal
p
seventi
patient
hypoxem
admiss
global
preval
hypoxemia
confid
interv
ci
median
iqr
without
differ
countri
iqr
mali
iqr
vadu
india
p
tabl
compar
characterist
hypoxem
nonhypoxem
patient
hiv
preval
n
median
weightforheight
z
score
iqr
median
length
hospit
stay
day
iqr
day
median
crp
level
admiss
mgl
iqr
mgl
median
white
blood
cell
count
cellsl
iqr
cellsl
median
neutrophil
proport
iqr
median
pct
level
admiss
ngml
iqr
ngml
mean
ngml
minimum
maximum
ngml
overal
test
posit
urinari
antibiot
admiss
among
patient
given
antibiot
hospit
median
durat
day
iqr
day
receiv
monotherapi
also
get
multipl
antibiot
line
main
drug
ceftriaxon
n
amoxicillin
n
ampicillin
n
amoxicillinsulbactam
n
amoxicillinclavulan
acid
n
oxacillin
n
vancomycin
n
hypoxem
n
nonhypoxem
n
pneumonia
case
differ
median
number
bacteria
versu
respect
p
virus
detect
versu
respect
p
nasal
swabsaspir
infect
type
bacterialviralmix
differ
hypoxem
nonhypoxem
patient
p
tabl
report
microbiolog
agent
link
hypoxemia
univari
analysi
disclos
hmpv
rsv
detect
nasal
sampl
associ
increas
risk
hypoxemia
p
respect
adjust
age
center
calendar
time
microorgan
independ
associ
heighten
risk
hypoxemia
hmpv
adjust
odd
ratio
aor
ci
rsv
aor
ci
median
lower
rsv
hmpvposit
patient
neg
patient
differ
rsv
hmpvposit
patient
figur
pneumococcu
serotyp
respiratori
sampl
frequent
hypoxem
nonhypoxem
patient
versu
respect
p
versu
respect
p
distribut
serotyp
significantli
differ
hypoxem
nonhypoxem
children
supplement
figur
hypoxem
patient
differ
nonhypoxem
patient
accord
age
p
histori
common
coldpharyng
p
receipt
one
dose
pentaval
vaccin
p
breath
rate
p
blood
pressur
p
chest
indraw
p
cyanosi
p
conjunct
p
rasp
p
radiolog
present
p
mean
white
blood
cell
count
p
pct
p
admiss
tabl
lr
lower
chest
indraw
ci
lr
ci
lr
cyanosi
ci
ci
sign
symptom
less
predict
hypoxemia
data
shown
hypoxem
patient
differ
nonhypoxem
patient
mean
white
blood
cell
count
p
pct
admiss
p
regard
crp
level
fourteen
patient
die
hospit
stay
among
die
within
day
hospit
admiss
mortal
rate
hypoxem
nonhypoxem
patient
p
eight
deceas
patient
hypoxem
admiss
among
caus
death
multipl
organ
dysfunct
syndrom
n
acut
respiratori
distress
syndrom
septic
shock
n
sever
pneumonia
hiv
n
cardiac
arrest
n
tabl
report
microbiolog
clinic
paraclin
find
associ
death
univari
cox
analysi
streptococcu
pneumonia
detect
blood
pcr
hypoxemia
pct
ngml
admiss
associ
increas
risk
death
logrank
test
p
p
p
respect
figur
characterist
microorgan
includ
pneumonia
respiratori
sampl
significantli
associ
death
supplement
tabl
pneumonia
serotyp
significantli
associ
higher
mortal
data
shown
streptococcu
pneumonia
detect
blood
pcr
hypoxemia
pct
ngml
admiss
link
augment
probabl
death
univari
surviv
analysi
crude
hazard
ratio
chr
ci
chr
ci
chr
ci
respect
associ
consist
bivari
cox
regress
adjust
countri
age
categori
hiv
seroposit
time
per
quarter
weightforheight
z
score
supplement
figur
addit
pneumonia
detect
blood
pcr
associ
increas
risk
death
aor
ci
independ
hypoxemia
admiss
aor
ci
one
object
studi
assess
microbiolog
agent
predictor
hypoxemia
death
hospit
children
pneumonia
develop
countri
observ
two
virus
name
rsv
hmpv
detect
respiratori
sampl
pcr
independ
associ
increas
risk
hypoxemia
bacteri
agent
significantli
link
hand
pneumonia
detect
blood
pcr
associ
higher
rate
inhospit
mortal
studi
popul
independ
hypoxemia
admiss
sever
predictor
hypoxem
pneumonia
identifi
howev
none
high
likelihood
ratio
elev
pct
concentr
hypoxemia
straightforward
predictor
death
children
pneumonia
contribut
hypoxemia
risk
death
independ
pneumococcu
detect
blood
pcr
sever
studi
investig
factor
associ
hypoxemia
particularli
clinic
howev
research
link
microbiolog
find
sever
differ
develop
countri
standard
protocol
observ
two
virus
associ
increas
risk
hypoxemia
viral
pneumonia
induc
diffus
bilater
pulmonari
compar
bacteri
pneumonia
frequent
wellsystemat
alveolar
probabl
reason
note
two
viral
etiolog
agent
evok
pneumonia
associ
hypoxemia
rsv
lead
caus
viral
pneumonia
frequent
associ
sever
observ
might
also
major
caus
hypoxem
pneumonia
hand
rsv
detect
relat
increas
mortal
estim
children
could
die
rsvassoci
pneumonia
worldwid
everi
year
studi
power
probabl
limit
demonstr
associ
howev
preval
exposur
nonhypoxem
patient
rang
bilater
test
studi
power
detect
similar
result
report
recent
studi
research
note
rsv
pneumonia
children
induc
complic
longer
durat
hospit
mortal
lower
comparison
agent
hmpv
recogn
frequent
etiolog
agent
pneumonia
caus
sever
determin
detect
viru
associ
hypoxem
pneumonia
children
find
might
relat
fact
two
virus
respiratori
sampl
might
etiolog
agent
pneumonia
anoth
hypothesi
might
associ
coinfect
howev
discern
relationship
infect
type
bacteri
viral
coinfect
risk
hypoxemia
main
clinic
predictor
hypoxem
pneumonia
lower
chest
indraw
cyanosi
lr
ratio
sign
present
hypoxemia
must
suspect
absenc
puls
oximetri
oxygen
therapi
initi
promptli
nevertheless
discern
one
sign
high
lr
ratio
confirm
puls
oximetri
import
initi
evalu
pneumonia
sever
implement
wide
develop
lower
chest
indraw
report
predict
hypoxemia
children
breath
rate
cyclesminut
encount
hypoxemia
children
papua
new
predictor
less
known
design
valid
simpl
robust
score
predict
hypoxemia
might
use
resourcelimit
set
streptococcu
pneumonia
recogn
main
etiolog
agent
sever
pneumonia
death
pneumonia
diagnosi
pneumococcu
pneumonia
howev
difficult
individu
level
low
sensit
blood
cultur
particularli
case
previou
exposur
antibiot
addit
clinic
mean
pneumococcu
detect
nasal
sampl
molecular
test
difficult
interpret
high
preval
pneumonia
respiratori
carriag
asymptomat
observ
associ
pneumococcu
detect
nasal
sampl
diseas
sever
although
pneumococcusposit
blood
pcr
link
greater
mortal
molecular
pneumonia
detect
blood
pcr
thu
help
identifi
bacteri
pneumonia
case
poorest
prognosi
might
need
intens
therapi
interpret
molecular
method
pcr
identifi
etiolog
pneumonia
children
howev
challeng
respiratori
virus
identifi
asymptomat
children
secondari
bacteri
infect
lung
easili
miss
method
addit
identif
pneumonia
blood
highli
sensit
pcr
may
detect
children
nasopharyng
colon
could
lead
potenti
misclassif
bia
particularli
use
result
nasopharyng
specimen
determin
etiolog
pneumonia
children
must
cautiou
result
interpret
moreov
pct
major
biomark
associ
inhospit
death
cohort
sever
studi
previous
found
associ
pct
risk
death
bacteri
howev
linkag
rare
seen
pneumoniainfect
children
live
develop
countri
main
strength
present
studi
prospect
data
collect
standard
form
differ
site
advanc
molecular
diagnosi
case
reinforc
intern
valid
main
limit
includ
pauciti
inform
exposur
hospit
admiss
ie
breastfeed
food
intak
vitamin
supplement
addit
microbiolog
diagnosi
pneumonia
difficult
sensit
specif
test
routin
avail
practic
thu
base
respiratori
sampl
unabl
differenti
colon
infect
particularli
howev
analysi
relationship
result
differ
sampl
sever
contribut
find
associ
nasal
colon
pneumococcu
diseas
sever
hypoxemia
death
final
select
bia
might
occur
patient
recruit
hospit
inclus
sever
case
patient
easier
access
care
howev
discern
signific
heterogen
regard
infant
admiss
inhospit
mortal
suggest
result
might
generaliz
differ
set
must
acknowledg
studi
popul
enrol
two
site
india
might
limit
extern
valid
proport
howev
accord
estim
global
pneumonia
incid
relat
mortal
india
might
account
almost
total
number
sever
pneumonia
case
children
number
death
conclus
rsv
hmpv
could
major
caus
hypoxemia
children
sever
pneumonia
develop
countri
pneumonia
detect
blood
pcr
predict
high
risk
inhospit
mortal
viral
etiolog
might
consid
hypoxem
patient
wherea
sever
pneumonia
lead
death
pneumonia
may
implic
primari
caus
even
absenc
hypoxemia
admiss
tachypnea
lower
chest
indraw
could
use
indic
possibl
hypoxemia
requir
oxygen
therapi
puls
oximetri
includ
better
diagnosi
develop
countri
given
find
prevent
measur
increas
vaccin
coverag
children
develop
countri
oxygen
therapi
hypoxem
patient
intens
cardiovascular
support
even
nonhypoxem
patient
would
reduc
burden
death
pneumonia
children
